<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01429506</url>
  </required_header>
  <id_info>
    <org_study_id>922861</org_study_id>
    <nct_id>NCT01429506</nct_id>
  </id_info>
  <brief_title>Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes</brief_title>
  <official_title>Effect of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this the investigators will be comparing the effects of Laparoscopic sleeve gastrectomy
      with intensive medical management on weight and metabolic parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intensive medical management will include

        1. VLCD

        2. Physical activity

        3. Exenatide

        4. Metformin

        5. Insulin detemir
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight loss</measure>
    <time_frame>6 months</time_frame>
    <description>weight loss at 6 months after the start of intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>glycemic control</measure>
    <time_frame>6 months</time_frame>
    <description>HbA1c and glucose profile</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will undergo laparoscopic sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive medical management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will receive VLCD, exenatide, metformin, insulin detemir</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sleeve gastrectomy</intervention_name>
    <description>Sleeve gastrectomy</description>
    <arm_group_label>Sleeve gastrectomy</arm_group_label>
    <other_name>Bariatric surgery</other_name>
    <other_name>Laparoscopic sleeve gastrectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intensive medical management</intervention_name>
    <description>Exenatide 10 mcg BD, Metformin 2-3 gm/day, 800 Kcal diet</description>
    <arm_group_label>Intensive medical management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Type 2 Diabetics with

          1. BMI â‰¥ 27.5 kg/m2

          2. HbA1c 7-10%

          3. Age 20-70 years

        Exclusion Criteria:

          1. Prior gastric surgery

          2. Pregnancy and lactation

          3. renal disease (GFR &lt; 60 ml/min)

          4. Pancreatitis

          5. Symptomatic gallstone disease

          6. Active malignancy

          7. Secondary causes of obesity ( Cushing's syndrome, uncontrolled Hypothyroidism)

          8. Severe psychiatric illness

          9. Allergic reaction to exenatide
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anil Bhansali, DM, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Postgraduate Institute of Medical Education and Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PGIMER</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2011</study_first_submitted>
  <study_first_submitted_qc>September 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2011</study_first_posted>
  <last_update_submitted>October 23, 2015</last_update_submitted>
  <last_update_submitted_qc>October 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Postgraduate Institute of Medical Education and Research</investigator_affiliation>
    <investigator_full_name>Anil Bhansali</investigator_full_name>
    <investigator_title>Professor, Department of endocrinology</investigator_title>
  </responsible_party>
  <keyword>Sleeve gastrectomy</keyword>
  <keyword>Intensive medical management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

